Becton, Dickinson(BDX)

Search documents
BDX vs. MMSI: Which Stock Is the Better Value Option?
Zacks Investment Research· 2024-04-03 16:41
Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Becton Dickinson (BDX) and Merit Medical (MMSI) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates a ...
BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
Prnewswire· 2024-03-21 10:50
FRANKLIN LAKES, N.J., March 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration (FDA) Safety Communication, which provided important updates on FDA's ongoing evaluation of certain plastic syringes: Eric Borin, president of BD Medication Delivery Solutions said, "BD has the capacity to support additional syringe demand and is further increasing ...
BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study
Prnewswire· 2024-03-18 10:50
COPENHAGEN, Denmark, March 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood collection tubes without compromising hygiene, safety or quality of the material. BD partnered with Odense University Hospital, the Health Innovation Centre of Southern Denmark, the Danish Technological Institute, the Global Material & Asset Fund and EcoFITT ApS to ...
BD's (BDX) ADC System Favored by New Study for Long-Term Care
Zacks Investment Research· 2024-03-14 17:01
Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced positive new data from a research study assessing the impact of deploying automated dispensing cabinets (ADCs) in long-term care facilities and an off-site, long-term care pharmacy. The novel, peer-reviewed study was published in the Journal of the American Pharmacists Association.The study evaluated various endpoints related to the management of first, missing and emergency dose medications over a 90-day period after replacing ...
Zeus Names New Chief Executive Officer
Prnewswire· 2024-03-14 17:00
Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership O'Brien currently serves as Worldwide President of BD Peripheral Intervention ORANGEBURG, S.C., March 14, 2024 /PRNewswire/ -- Zeus, the world's leading polymer extrusion and catheter design manufacturer, is excited to announce the appoi ...
New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities
Prnewswire· 2024-03-13 10:50
Results Show Clinical Workflow, Operational Efficiency and Financial Improvements When Using Automated Dispensing Cabinets FRANKLIN LAKES, N.J., March 13, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data from a research study evaluating the impact of deploying automated dispensing cabinets in long-term care facilities and an off-site, long-term care pharmacy. Over a 90-day period in the long-term care facilities, me ...
Here's Why You Should Retain BD (BDX) to Your Portfolio
Zacks Investment Research· 2024-03-12 15:36
Becton, Dickinson and Company (BDX) , popularly known as BD, is well-poised for growth in the coming quarters, courtesy of its series of product launches over the past few months. The optimism led by a solid first-quarter fiscal 2024 performance and a few strategic deals are expected to contribute further. However, macroeconomic concerns and stiff competition persist.Over the past year, this Zacks Rank #3 (Hold) stock has gained 3.5% compared with the 18.1% rise of the industry and 32.9% growth of the S&P 5 ...
BD (BDX) Initiates IDE Study to Aid Treatment of Artery Disease
Zacks Investment Research· 2024-03-05 14:31
Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced the enrollment of the first patient in the investigational device exemption (IDE) study, AGILITY, which aims to evaluate the efficacy and safety of the BD Vascular Covered Stent in treating peripheral arterial disease (PAD).The first patient in the AGILITY study was enrolled at Trinity Medical Center in Bettendorf, Iowa, by Dr. Nicolas Shammas, Interventional Cardiologist, Cardiovascular Medicine, PLLC.Price PerformanceFor the p ...
3 Stocks to Buy at 52-Week Lows: March 4 Edition
InvestorPlace· 2024-03-04 22:35
Dumpster diving can be fun! One man’s trash is another’s treasure, particularly when investing. Stocks tossed into the trash and trading at 52-week lows can many times turn into real jewels for your portfolio.Of course, you should use caution. Just because a stock is down does not make it a buy. Cheap stocks are often cheap for a reason. You can’t readily fix them because something is wrong with the business. Avoid those stocks at all costs. You don’t want your portfolio to be like an episode of TV’s Hoarde ...
BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease
Prnewswire· 2024-03-04 11:50
First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PADFRANKLIN LAKES, N.J., March 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the investigational device exemption (IDE) study, "AGILITY," which will assess the safety and effectiveness of the BD Vascular Covered Stent for the treatment of Periphera ...